Analytical Data
-
Gene name
CKLFSF6
- Application
-
Alternative Names
CKLFSF6；CKLFSF6；CKLF-like MARVEL transmembrane domain-containing Protein 6
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NX76
-
Expression Region
1-183aa
-
AA Sequence
MENGAVYSPTTEEDPGPARGPRSGLAAYFFMGRLPLLRRVLKGLQLLLSLLAFICEEVVSQCTLCGGLYFFEFVSCSAFLLSLLILIVYCTPFYERVDTTKVKSSDFYITLGTGCVFLLASIIFVSTHDRTSAEIAAIVFGFIASFMFLLDFITMLYEKRQESQLRKPENTTRAEALTEPLNA
-
Molecular Weight
20.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CKLFSF6 is a member of the CKLF-like MARVEL transmembrane domain-containing (CMTM) family, which plays essential roles in various biological processes, including immune response and cell signaling. The exploration of CKLFSF6 has gained significant interest due to its potential implications in cancer biology and immune modulation. Research has indicated that CKLFSF6 may influence tumor growth and metastasis, suggesting a role in cancer progression. Furthermore, its expression patterns in different tissues and cell types have prompted investigations into its functional significance in regulating immune cell functions. Understanding the structure and function of CKLFSF6 at the molecular level is critical for elucidating its biological roles and therapeutic potential. Recent advancements in recombinant protein technology have facilitated the production of CKLFSF6 for comprehensive studies, enabling researchers to probe its interactions, signaling pathways, and potential as a biomarker or target for novel therapies. Overall, the investigation of CKLFSF6 offers promising insights into the complexities of cellular communication and the development of innovative strategies for disease intervention.
